Skip to main content

Interactive Features

Annals of Long-Term Care
Michael Fralick, MD, FRCPC, Brigham and Women’s Hospital, discusses his recent study that examined a medication approved for psuedobulbar affect, which he found was regularly being prescribed to patients with PD and dementia. He explains why these prescribing habits are concerning.  …
Back to Top